Association between Serum Interleukin-6 Concentration and Mortality in Patients with Coronary Artery Disease
Open Access
- 1 January 2013
- journal article
- review article
- Published by Hindawi Limited in Mediators of Inflammation
- Vol. 2013, 1-7
- https://doi.org/10.1155/2013/726178
Abstract
Objectives. To evaluate whether serum interleukin-6 (IL-6) is associated with increased risk of mortality in coronary artery disease (CAD) patients.Methods. We performed a prospective cohort study of 718 CAD patients from the Guangzhou Cardiovascular Disease Cohort (GCDC) study. Multivariable-adjusted Cox proportional hazards regression analyses were used to examine the association between serum IL-6 with all-cause and cardiovascular mortality.Results. During the 1663 person-years of followup, the cumulative all-cause mortality and cardiovascular mortality were 6.5% () and 3.3% (), respectively. The mean length of followup wasyears. In the multivariable analyses, a one-SD increment in log-transformed serum IL-6 was positively associated with an increased risk of all-cause and cardiovascular mortality, with hazard ratios (HR) of 2.93 (95% CI, 2.11–4.08) and 2.04 (95% CI, 1.34–3.68) within the patients combined and 2.98 (95% CI, 2.12–4.18) and 3.10 (95% CI, 1.98–4.85) within males, respectively. Patients in the highest serum IL-6 tertile versus the lowest tertile were at higher risk of all-cause and cardiovascular mortality, with HR of 17.12 (95% CI 3.11–71.76) and 8.68 (95% CI, 1.88–37.51), respectively.Conclusions. In hospitalized patients with CAD, serum IL-6 is significantly associated with all-cause and cardiovascular mortality.
Keywords
Funding Information
- 501100001809 National Natural Science Foundation of China (81130052, 81010017)
This publication has 32 references indexed in Scilit:
- Lack of association between four SNPs in the SLC22A3-LPAL2-LPA gene cluster and coronary artery disease in a Chinese Han population: a case control studyLipids in Health and Disease, 2012
- The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysisThe Lancet, 2012
- Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studiesThe Lancet, 2012
- Relationship between lipid profiles and plasma total homocysteine, cysteine and the risk of coronary artery disease in coronary angiographic subjectsLipids in Health and Disease, 2011
- Heart Disease and Stroke Statistics—2011 UpdateCirculation, 2011
- Systemic inflammation (Interleukin 6) predicts all-cause mortality in men: results from a 9-year follow-up of the MEMO StudyAGE, 2010
- Cholesteryl Ester Transfer Protein and Mortality in Patients Undergoing Coronary AngiographyCirculation, 2010
- Inflammatory biomarkers in coronary artery diseaseJournal of Cardiology, 2009
- Biomarkers to Predict Recurrent Cardiovascular Disease: The Heart and Soul StudyAmerican Journal Of Medicine, 2008
- Three‐Year Change in Inflammatory Markers in Elderly People and Mortality: The Invecchiare in Chianti StudyJournal of the American Geriatrics Society, 2007